Heron Therapeutics
HRTX
#7580
Rank
C$0.38 B
Marketcap
$2.55
Share price
0.00%
Change (1 day)
-31.73%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.62. In 2022 the company made an earnings per share (EPS) of -$2.40 an increase over its 2021 EPS that were of -$3.12.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-34.07%
2022-$2.40-23.11%
2021-$3.12-10%
2020-$3.46-0%
2019-$3.461.21%
2018-$3.42-32.7%
2017-$5.08-19.34%
2016-$6.3054.76%
2015-$4.071.73%
2014-$4.00-16.23%
2013-$4.7891.67%
2012-$2.49-31.45%
2011-$3.64-27.06%
2010-$4.98-43.75%
2009-$8.86-57.33%
2008-$20.77-82.92%
2007-$121.5720.61%
2006-$100.80175.76%
2005-$36.55-21.43%
2004-$46.52100%
2003-$23.26-38.24%
2002-$37.66161.54%
2001-$14.40-106.46%
2000$222.782051.55%
1999$10.35839.73%
1998$1.10-105.48%
1997-$20.12-88.16%
1996-$169.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.80-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.19-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.26 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.17-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.28 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA